Depolarizing stimuli increase catecholamine (CA) biosynthesis, tyrosine hydroxylase (TH) activity, and TH phosphorylation at Ser19, Ser31, and Ser40 in a Ca 21 -dependent manner. However, the identities of the protein kinases that phosphorylate TH under depolarizing conditions are not known. Furthermore, although increases in Ser31 or Ser40 phosphorylation increase TH activity in vitro, the relative in¯uence of phosphorylation at these sites on CA biosynthesis under depolarizing conditions is not known. We investigated the participation of extracellular signal-regulated protein kinase (ERK) and cAMP-dependent protein kinase (PKA) in elevated K 1 -stimulated TH phosphorylation in PC12 cells using an ERK pathway inhibitor, PD98059, and PKA-de®cient PC12 cells (A126-B1). In the same paradigm, we measured CA biosynthesis. TH phosphorylation stoichiometry (PS) was determined by quantitative blot-immunolabeling using siteand phosphorylation state-speci®c antibodies. Treatment with elevated K 1 (158 mM) for 5 min increased TH PS at each site in a Ca 21 -dependent manner. Pretreatment with PD98059
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prevented elevated K 1 -stimulated increases in ERK phosphorylation and Ser31 PS. In A126-B1 cells, Ser40 PS was not signi®cantly increased by forskolin, and elevated K 1 -stimulated Ser40 PS was three-to ®ve-fold less than that in PC12 cells. In both cell lines, CA biosynthesis was increased 1.5-fold after treatment with elevated K 1 and was prevented by pretreatment with PD98059. These results suggest that ERK phosphorylates TH at Ser31 and that PKA phosphorylates TH at Ser40 under depolarizing conditions. They also suggest that the increases in CA biosynthesis under depolarizing conditions are associated with the ERK-mediated increases in Ser31 PS. Tyrosine hydroxylase (TH) is the rate-limiting enzyme in catecholamine (CA) biosynthesis. Treatments that mimic depolarization in situ increase CA biosynthesis, TH activity, and phosphorylation of TH in a Ca 21 -dependent manner (Yanagihara et al. 1984; Waymire et al. 1988; Mitchell et al. 1990; Haycock and Wakade 1992) . Electrical stimulation of the medial forebrain bundle also increases CA biosynthesis, TH activity, and phosphorylation at Ser19, Ser31, and Ser40 in the striatum (Haycock and Haycock 1991) . Prolonged electrical stimulation does not deplete cellular CA levels except in the presence of a TH inhibitor (Wakade 1988; Wakade et al. 1988) . Thus, depolarizing stimulation appears to activate one or more Ca 21 -in¯ux-activated protein kinases that phosphorylate TH at speci®c sites. The phosphorylation of one or more of these sites increases TH activity and CA biosynthesis.
The identity of the protein kinases that phosphorylate TH under depolarizing conditions and the site or sites whose phosphorylation regulates TH activity and CA biosynthesis are not known. Extracellular signal-regulated protein kinase (ERK) can be activated by depolarizing stimuli in a Ca 21 -dependent manner (Pavlovic-Surjancev et al. 1992; Frodin et al. 1995; Rosenblum et al. 2000) and is the only protein kinase known to phosphorylate Ser31 both in vitro and in situ Sutherland et al. 1993; Thomas et al. 1997) . Treatments that increase Ser31 phosphorylation alone, such as nerve growth factor (NGF) treatment (Haycock 1990) , increase TH activity (Mitchell et al. 1990 ). Ser31 phosphorylation may also increase CA biosynthesis under depolarizing conditions. In cells transfected with TH mutated at Ser40, treatment with elevated K 1 increases CA biosynthesis in a manner comparable to that observed in cells transfected with wild-type TH (Harada et al. 1996) . Increases in Ser19 phosphorylation do not appear to directly in¯uence TH activity or CA biosynthesis in situ Lindgren et al. 2000) . Ca 21 /calmodulin-dependent protein kinase II (CAMKII) phosphorylates both Ser19 and Ser40 in vitro (Campbell et al. 1986; Funakoshi et al. 1991; Sutherland et al. 1993; Alterio et al. 1998) and is also activated by depolarizing stimulation (Colbran 1992; Hanson and Schulman 1992) . Although the site on TH phosphorylated by CAMKII in situ is unknown, it has been long proposed that CAMKII phosphorylation of TH is involved in depolarization-stimulated CA biosynthesis. A CAMKII inhibitor, KN-93, has been shown to inhibit depolarization-stimulated TH phosphorylation and CA biosynthesis (Sumi et al. 1991) . cAMP-dependent protein kinase (PKA), shown to phosphorylate Ser40 exclusively in vitro (Vulliet et al. 1980; Funakoshi et al. 1991; Sutherland et al. 1993) , can also have its activity increased under depolarizing conditions (Shimizu et al. 1970; Baizer and Weiner 1985; Keogh and Marley 1991) . Increases in Ser40 phosphorylation are associated with increases in TH activity and CA biosynthesis not only in situ [in chromaf®n and PC12 cells (Haycock 1990; Waymire et al. 1991) ] and striatal slices (Lindgren et al. 2000) , but in vivo as well . However, in addition to being phosphorylated by CAMKII and PKA, Ser40 is also phosphorylated in vitro by protein kinase C (Albert et al. 1984; Funakoshi et al. 1991) , protein kinase G (Roskoski et al. 1987) , and mitogen-activated protein kinaseactivated kinases 1 and 2 (Sutherland et al. 1993) . Of these protein kinases, only PKA has been shown to directly phosphorylate Ser40 in situ (Haycock 1996b) . These studies indicate that the cellular mechanism by which depolarization increases CA biosynthesis is by either (i) CAMKIImediated phosphorylation of Ser40, (ii) ERK-mediated phosphorylation of Ser31, (iii) PKA-mediated phosphorylation of Ser40, or (iv) Ser40 phosphorylation by a protein kinase other than CAMKII or PKA.
The phosphorylation stoichiometry (PS) of TH in vivo has been reported recently (Salvatore et al. 2000) , and sitespeci®c TH PS in PC12 cells ) is comparable to that observed in the nigrostriatal and mesolimbic systems (Salvatore et al. 2000) . Thus PC12 cells are an appropriate model in which to study the regulation of TH phosphorylation and its relationship to CA biosynthesis. We used two PC12 cell lines, one de®cient in the capacity to stimulate PKA activity (van Buskirk et al. 1985; Ginty et al. 1991) . The major objectives were to determine the involvement of CAMKII, ERK, and/or PKA in depolarization-stimulated site-speci®c TH phosphorylation and in CA biosynthesis.
Materials and methods
Cell culture PC12 and A126-B1 cells (van Buskirk et al. 1985) were propagated on 75-cm 2 tissue culture¯asks (Falcon, Franklin Lakes, NJ, USA) pretreated with 2 mg/cm 2 human placental collagen (Sigma, St Louis, USA; catalog no. C 7521). The growth medium was a 1 : 1 combination of Dulbecco's modi®ed Eagle medium/F12 (Gibco BRL, Gaithersburg, MD, USA; catalog no.10565±018) and OPTI-MEM I reduced serum medium (Gibco BRL; catalog no. 51985±034) containing 5% heat-inactivated fetal bovine serum (Gibco BRL), 5% heat-inactivated donor horse serum (JRH Biosciences, Lenexa, KS, USA), and penicillin (25 U/mL)/streptomycin (25 mg/mL) (Gibco BRL). For experiments, cells were subcultured onto either 12-or 24-well tissue culture plates [Falcon or Costar (Cambridge, MA, USA)], pretreated with 2 mg/cm 2 human placental collagen, in the same media composition used for propagation. Incubation conditions were 36±378C in a humidi®ed atmosphere of 6.0±6.5% CO 2 .
Drugs and reagents
Forskolin was purchased from Tocris (Baldwin, MO, USA). NGF (rat recombinant) was purchased from Sigma. KN-92 and KN-93 were purchased from Calbiochem (La Jolla, CA, USA) and Seikagaku Corporation (Tokyo, Japan). PD98059 was purchased from Calbiochem. Dimethyl sulfoxide (DMSO) (cell culture reagent grade) was purchased from Sigma (St Louis, MO, USA). All drugs, with the exception of NGF, were dissolved into DMSO to stock concentration and diluted accordingly into treatment buffers.
General experimental conditions
Upon reaching at least 50% con¯uence, cells were washed with phosphate-buffered saline (Gibco BRL) and pre-incubated (60± 90 min) in pH 7.3±7.4 buffer (124 mm NaCl, 25 mm NaHCO 3 , 11 mm glucose, 10 mm HEPES, 4 mm KCl, 2 mm MgSO 4 , 2 mm CaCl 2 , and 1.2 mm KH 2 PO 4 ) used throughout the experimental procedures. After pre-incubation, the buffer was aspirated and replaced for 10±30 min of pretreatment with selected compounds. In all experiments, theophylline (100 mm; Sigma) was added to each well for the ®nal 10 min of pretreatment to reduce adenosinergic stimulation of cellular cAMP levels (Roskoski and Roskoski 1989) . Treatments were initiated by adding buffer or K 1 buffer (in which 58 mm NaCl was replaced with 58 mm KCl) containing, as indicated in the Results section, additional compounds and/or l-[1±
14
C]tyrosine, as appropriate, for up to 10 min (see Results). During treatment, buffer temperature was maintained at 33±368C. Two methods were used to stop treatment effects. In experiments wherein only TH PS was determined, reactions were stopped by aspirating treatment buffer and adding 1% sodium dodecyl sulfate (SDS) solution (pH 8.3 with ,5 mm Tris-HCl and 1 mm EDTA). Solubilized total cellular protein was harvested with trituration and heated for ,5 min. In experiments wherein both CA biosynthesis and TH PS were determined, reactions were stopped by adding an equal volume of 0.4 mm perchloric acid. Cells were triturated and wells were scraped to suspend attached protein. The entire sample was harvested, and precipitated protein was recovered by centrifugation, solubilized in 1% SDS/Tris/EDTA, neutralized with pH 8.9 Tris-HCl, and heated for 5 min. Total protein in each sample, stopped by either method, was determined using the bicinchoninic acid method (Smith et al. 1985) .
Primary antibodies and blot immunolabeling standards
The characterization of the primary antibodies and standards used to assay tTH and TH PS have been previously described Salvatore et al. 2000) . Primary antibodies used to detect CAMKII were a goat polyclonal antibody generated against the N-terminal region of CAMKII (Calbiochem, San Diego, CA, USA) and a mouse monoclonal antibody (Transduction Laboratories, Lexington, KY, USA). Both were diluted to 1 mg/mL for assay. Ca 21 /calmodulin-dependent protein kinase IV (CAMKIV) levels were analyzed using a mouse monoclonal antibody and Jurkat cell lysate (as a positive control) from Transduction Laboratories. Rabbit antibody speci®c for ERK1/ERK2 was purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA) and used to determine total ERK1/ERK2. Rabbit antibody used for detection of diphosphorylated ERK (Haycock 1996a ) was purchased from Promega (Madison, WI, USA).
Blot immunolabeling and determination of tTH and TH PS As described in detail (Haycock 1993b; Salvatore et al. 2000) , aliquots of samples (normalized for total protein) were subjected to SDS±polyacrylamide gel electrophoresis. For each assay of tTH or TH PS, a range of calibrated standards was included in the electrophoresis run. After electrophoresis, sample proteins were transferred overnight in Tris/glycine/methanol buffer onto nitrocellulose membranes (Bio-Rad Laboratories, Hercules, CA, USA). Uniformity of protein transfer was veri®ed by Ponceau S staining of the nitrocellulose membranes. The membranes were immersed in quenching buffer containing 1% polyvinylpyrrolidone and 0.05% Tween 20 for a minimum of 2 h before incubation with primary antibody for 1±2 h, 1 h incubation with secondary antibody (as appropriate: swine anti-rabbit IgG and rabbit anti-mouse IgG 1 , 0.5 mg/mL, Dako, Glostrup, Denmark; rabbit anti-goat IgG, 0.8 mg/mL, Accurate Chemical and Scienti®c Corp., Westbury, NY, USA), and 1 h incubation with [ 125 I]protein A (speci®c activity ,30 mCi/mg; Amersham, Piscataway, NJ, USA).
tTH and site-speci®c phospho-TH values were determined in separate blots for each primary antibody by quantifying gamma radioactivity per sample and interpolating against the standard curve generated for each assay, as described (Salvatore et al. 2000) . TH PS for each site was obtained by dividing ng of phospho-TH by ng of tTH.
CA biosynthesis assay
All CA biosynthesis experiments were done in 24-well cell culture plates (CoStar). The method used to quantify evolved [ 14 C]CO 2 after termination of treatments was adapted from previous procedures (Meligeni et al. 1982; Cheah et al. 1999) . l-[1±
14
C]Tyrosine (speci®c activity 54 mCi/mmol; Moravek Biochemicals Inc., Brea, CA, USA) was dried under nitrogen and reconstituted in treatment buffers to generate 0.5 mCi/mL. After 30 min pretreatment, each well was ®tted with a section of Tygon tubing to collect [ 14 C]CO 2 evolved during treatment (as illustrated in Cheah et al. 1999 ). An equal volume of buffer or K 1 buffer containing l-[1±
C]tyrosine, with or without treatment compound, was added to initiate treatment. After perchloric acid was added to terminate treatment, a rubber stopper ®tted with a suspended plastic well containing Whatman-3 ®lter paper, saturated with Soluene-350 (Packard, Meriden, CT, USA), was placed immediately into the tubing. After allowing absorption of the evolved CO 2 for 45 min, the ®lter paper was transferred into scintillation cocktail (Hionic-Fluor, Packard) and (Meligeni et al. 1982) , and the levels of tTH and THPS recovered from perchloric acid pellets are equal to those from matched samples prepared by the direct SDS-solubilization procedure described above (J. W. Haycock, unpublished observations).
Statistical analyses
In experiments where only blot immunolabeling was analyzed, a paired Student's t-test ( p , 0.05) was used when only two treatment groups were studied, and a repeated measures anova and subsequent least signi®cant difference tests were used when more than two treatment groups were studied ( p , 0.05).
In experiments wherein TH PS and CA biosynthesis were both analyzed, treatment-associated TH PS and evolved-CO 2 values were divided by the operationally matched control values to determine treatment effects on TH PS and CA biosynthesis (expressed as percent of control). Both dependent measures were taken from the same well of cells. All data presented re¯ect observations from at least two independent experiments. A repeated measures anova test was used to determine signi®cant differences in the effects of elevated K 1 treatment and PD98059 pretreatment for each cell line. Thus, a total of four groups (buffer, with and without PD98059 pretreatment; K 1 buffer, with and without PD98059 pretreatment) were analyzed for each cell line. If a signi®cant difference ( p , 0.05) was detected among these four groups, a Bonferroni's multiple comparison test was applied to identify signi®cant differences between group means ( p , 0.05). Tukey's multiple comparison test and Student's paired t-test were used to determine signi®cant differences ( p , 0.05) in the results from the forskolin and NGF experiments.
Results

TH phosphorylation stoichiometry in PC12 and A126±B1 cells
Basal TH PS at each phosphorylation site in both cell lines is presented in Table 1 . There were no signi®cant differences in TH PS at Ser19 or Ser31 between the two cell lines. However, Ser40 PS was three-to four-fold lower in A126-B1 cells than in PC12 cells. The lower Ser40 PS in the A126-B1 cell line is consistent with the diminished PKA activity described in this cell line (van Buskirk et al. 1985) . Total TH in each cell line is also presented in Table 1 . A126-B1 cells had about 25% less tTH per protein than did the PC12 cells.
Effects of elevated K
1 on TH PS in PC12 and A126-B1 cells In both cell lines, elevated K 1 treatment increased Ser19 PS and Ser31 PS two-to four-fold ( Fig. 1) and Ser40 PS about 1.4-fold (Fig. 2a) . Despite the same fold increase in Ser40 PS between the two cell lines, the absolute increase in Ser40 PS after treatment with elevated K 1 differed by about ®ve-to seven-fold between the two cell lines (in PC12, 0.020; in A126-B1, 0.003). The absolute values of Ser40 PS in elevated K 1 -treated cells were 0.056 in PC12 cells and 0.011 in A126-B1 cells (Fig. 2a) . Elevated K 1 -stimulated increases in TH PS required extracellular Ca 21 : When CaCl 2 was omitted from the control and elevated K 1 buffers, there was no increase in PS at any phosphorylation site after 1, 3, or 5 min of elevated K 1 treatment (Table 2) . The extent to which PKA might be involved in the K 1 -dependent increase in Ser40 PS in A126-B1 cells was tested by treating the cells with forskolin, a robust activator of adenylyl cyclase. In PC12 cells, relatively low concentrations of forskolin increased Ser40 PS (Fig. 2b) , up to threefold at 0.3 mm (data not shown). In contrast, Ser40 PS in A126-B1 cells was unaffected by forskolin (Fig. 2b) , up to 0.3 mm (data not shown), thus demonstrating the inability of PKA to be activated in these cells and suggesting that the elevated K However, CAMKII protein immunoreactivity was present in and not discernibly different between the PC12 and A126-B1 cells (Fig. 3a) , suggesting that the large difference in the magnitude of Ser40 PS between the two cell lines after elevated K 1 treatment was not due to a difference in the abundance of CAMKII protein. As such, CAMKII could mediate the small depolarization-stimulated increase in Ser40 PS seen in A126-B1 cells. Another Ca
21
-dependent protein kinase that phosphorylates TH in vitro is CAMKIV (Miyano et al. 1992) . However, CAMKIV was not detected in either cell line (Fig. 3b) .
A potential involvement of CAMKII in elevated K 1 -stimulated Ser19 phosphorylation was tested using a CAMKII inhibitor (KN-93) and its inactive congener (KN-92). Although KN-93 (10 or 15 mm, 20±30 min) inhibited the elevated K 1 -stimulated increase in Ser19 PS by 80±100%, KN-92 inhibited the increase in Ser19 PS by nearly 50% under identical conditions (data not shown). The effects of KN-93 and KN-92 were not restricted to Ser19 PS. Elevated K 1 -stimulated increases in both Ser31 and Ser40 PS were also inhibited by 50±100% by KN-92 or KN-93. (data not shown). The effects of KN-93 on depolarization-stimulated Ser31 or Ser40 PS were, however, not due to a direct inhibition of ERK-or PKA-mediated phosphorylation of TH, because KN-93 did not reduce the increases in either Ser31 PS or Ser40 PS, associated with NGF (50 ng/mL) or forskolin (0.03 mm) treatment, respectively (data not shown). The non-speci®c effects of KN-93 on TH PS (Table 2 ) may re¯ect its effects on Ca 21 -channels, as demonstrated in bovine chromaf®n cells (Maurer et al. 1996) . [In an attempt to create a more speci®c CAMKII inhibitor, either the autoinhibitory peptide or pseudosubstrate sequence (Ishida et al. 1995) was coupled to the Pro50-substituted cell membrane-permeable peptide (Derossi et al. 1996) . However, concentrations up to 100 mm and pretreatment durations up to 1 h failed to inhibit elevated K 1 -stimulated increases in TH PS at Ser19 (data not shown).]
Effects of PD98059 on TH PS and ERK phosphorylation PD98059 inhibits MEK activation and thereby inhibits the activation of ERK (Alessi et al. 1995; Dudley et al. 1995) . Changes in ERK activity have been correlated directly with changes in Ser31 phosphorylation . PC12 cells were processed as in Table 1 with the exception that after pretreatment, elevated K 1 buffer either without (0 mM CaCl 2 ) or with (2 mM CaCl 2 ) was added for the indicated durations. Each of the values is presented as mean^SEM (n 4) percentage of basal TH PS determined as in Table 1 . Omission of CaCl 2 from the buffer during the last 10 min of pretreatment caused a slight, but signi®cant, reduction in basal Ser19 PS. Under basal conditions, pretreatment with PD98059 (30 mm, 30 min) reduced Ser31 PS three-fold in both PC12 and A126-B1 cells (Fig. 4a) . Ser19 PS was not affected in either cell line (Fig. 4b) . PD98059 pretreatment increased Ser40 PS in PC12 cells by 40% and Ser40 PS in A126-B1 cells was unaffected (Fig. 4c) .
Pretreatment with PD98059 blocked the elevated K 1 -stimulated increase in Ser31 PS in both the PC12 and A126-B1 cells (Fig. 4a) . In both cell lines, PD98059 reduced the K 1 -stimulated increase in Ser19 PS 25±30% (Fig. 4b) . In PD98059-treated PC12 cells, there was no increase in Ser40 PS after K 1 -treatment, perhaps as a result of the elevated basal Ser40 PS. However, absolute Ser40 PS from elevated K 1 treatment was unaffected by PD98059 pretreatment. In A126-B1 cells pretreated with PD98059, the apparent decrease in the K 1 -stimulated Ser40 PS was not statistically signi®cant. The ef®cacy of PD98059 in inhibiting elevated K 1 -stimulated ERK phosphorylation under the experimental conditions used is illustrated in Fig. 5 . Taken together with the observations that ERK phosphorylates Ser31 both in vitro and in situ, these results indicate that ERK1/ERK2 mediated the elevated K 1 -stimulated increase in Ser31 phosphorylation, as previously suggested by Halloran and Vulliet (1994) in bovine chromaf®n cells.
Effects of elevated K
1 on CA biosynthesis in PC12 and A126-B1 cells Treatment with elevated K 1 signi®cantly increased CA biosynthesis 1.5-fold in both cell lines (Fig. 6) . However, pretreatment of either cell line with PD98059 prevented the depolarization-induced increase in CA biosynthesis (Fig. 6 ). These data, in conjunction with the preceding data, suggest that ERK activation and subsequent phosphorylation of Ser31 is responsible for elevated K 1 -stimulated increases CA biosynthesis. These data also suggest that elevated K 1 -stimulated increases Ser19 PS or Ser40 PS may have little to no in¯uence on CA biosynthesis. In PC12 cells, Ser19 PS and Ser40 PS associated with elevated K 1 treatment were not lowered signi®cantly by pretreatment with PD98059 (Fig. 4) ; yet, PD98059 effectively prevented any K 1 -stimulated increase in CA biosynthesis in both cell lines (Fig. 6) . And, even though pretreatment with PD98059 increased Ser40 PS in PC12 cells under basal conditions to an extent similar to that produced by elevated K 1 (Fig. 4c) , basal CA biosynthesis was not increased but, in fact, reduced under these conditions (Fig. 6a) . Furthermore, K 1 -stimulated CA biosynthesis was of the same magnitude in both cell lines, despite a ®ve-fold difference in Ser40 PS between the two cell lines after elevated K 1 treatment (Fig. 4c) . In A126-B1 cells, Ser19 PS was increased 2.7-fold by elevated K 1 in the presence of PD98059 while elevated K 1 -stimulated CA biosynthesis was completely prevented (Figs 4b and 6b) .
Effects of forskolin on CA biosynthesis
The role of Ser40 PS in K 1 -stimulated CA biosynthesis in PC12 cells was further evaluated by treating cells with forskolin under conditions (0.03 mm, 5 min) that produced an increase in Ser40 PS comparable to that produced by elevated K 1 treatment (Fig. 2) . The goal here was to determine whether this magnitude of change in Ser40 PS would, alone, increase CA biosynthesis in these cells in a manner comparable to elevated K 1 treatment. Treatment of PC12 cells with 0.03 mm forskolin did not increase CA biosynthesis despite a two-fold increase in Ser40 PS (Table 3) . However, treatment with a higher concentration of forskolin (0.30 mm) increased Ser40 PS 3-fold and increased CA biosynthesis about 1.7-fold (Table 3) . Forskolin treatment at any concentration tested (0.03±0.3 mm) did not signi®cantly affect Ser19 or Ser31 PS (data not shown). These results, taken together with the observation that PD98059 blocks elevated K 1 -stimulated increases in CA biosynthesis in PC12 and A126-B1 cells, indicates that the Ser40 PS stimulated by elevated K 1 is not involved in the depolarization-dependent increase in CA biosynthesis.
Effects of NGF on CA biosynthesis
The role of Ser31 PS in K 1 -stimulated CA biosynthesis was further evaluated by treating cells with NGF under conditions (50 ng/mL, 5 min) that produced an increase in Ser31 PS comparable to that produced by elevated K 1 treatment. This NGF treatment increased Ser31 PS 2.6-fold in PC12 cells (Fig. 7b, left) and four-fold in A126-B1 cells (data not shown) while CA biosynthesis was increased ,1.5-fold in either cell line (Fig. 7a, left) . A longer NGF treatment (10 min) produced a larger increase in Ser31 PS in both cell lines (data not shown), however, the associated CA biosynthesis was not further increased by the longer treatment (data not shown). Thus, although the NGF-stimulation of Ser31 PS and CA biosynthesis supports the conclusion that increasing Ser31 PS to the same magnitude as that produced by elevated K 1 is suf®cient to increase CA biosynthesis, the data also indicate that the additional increases in Ser31 PS do not cause further increases in CA biosynthesis. PC12 cells were processed as in Table 1 with the exception that after pretreatment, buffer containing the indicated concentrations of forskolin was added. Treatment duration was 5 min. Wells and samples were processed for concurrent determination of TH PS and CA biosynthesis as described under Materials and methods. Control values are presented as mean^SEM (n 6) and forskolin-treated (n 2) sample data is presented for each sample. -stimulated CA biosynthesis in PC12 and A126-B1 cells. Cells were pretreated (30 min) in the absence or presence (1 PD) of 30 mM PD98059. After pretreatment, cells were treated for 5 min with buffer (B) or elevated K 1 buffer (K), and wells and samples were processed for concurrent determination of TH PS and CA biosynthesis as described under Materials and methods. Each bar and associated error bar represents the mean^SEM (n 6). TH PS data from the same samples in the experiment shown above are presented in Fig. 4 . The data shown are representative of the results from two independent experiments.
The involvement of Ser31 phosphorylation in CA biosynthesis regulation by NGF was also tested by treating cells with NGF after pretreatment with PD98059. PD98059 pretreatment reduced basal Ser31 PS in PC12 cells (Fig. 7b , left; see also Fig. 4a ) and in A126-B1 cells (data not shown). Furthermore, PD98059 pretreatment reduced the NGFstimulated increase in Ser31 PS in PC12 cells (Fig. 7b , right) and in A126-B1 cells (data not shown). Stimulation of phosphoERK immunoreactivity by NGF was also reduced by PD98059 pretreatment in both cell lines (data not shown). Pretreatment with PD98059 completely blocked the NGF-stimulated increase in CA biosynthesis in PC12 cells (Fig. 7a, right) and in A126-B1 cells (data not shown). Taken together, these data support the conclusion that the magnitude of increase in Ser31 PS that is produced by elevated K 1 treatment is necessary and suf®cient to increase CA biosynthesis.
Discussion
Depolarization-dependent stimulation of TH phosphorylation, TH activity, and CA biosynthesis has been established to be Ca 21 -dependent (Yanagihara et al. 1984; Waymire et al. 1988; Mitchell et al. 1990; Haycock and Wakade 1992) . However, the identities of the protein kinases involved in depolarization-stimulated TH phosphorylation at Ser19, Ser31, and Ser40, and the involvement of these sites in regulating CA biosynthesis are not well characterized. Using site-and phosphorylation state-speci®c antibodies directed toward Ser19, Ser31, or Ser40, we have shown that depolarization increases the PS of all three sites in Ca 21 -dependent manner. This con®rms and extends studies which used 32 P-labeling to study site-speci®c TH phosphorylation (Waymire et al. 1988; Haycock 1990 ). Thus, the depolarization-dependent acceleration of CA biosynthesis must involve the phosphorylation of one or more of these phosphorylation sites via a protein kinase(s) that requires (directly or indirectly) extracellular Ca 21 for activation. Our approach of assessing the PS of each phosphorylation site using a MEK inhibitor (PD98059, to prevent ERK activation) in both`normal' PC12 cells and PC12 cells de®cient in the ability to activate PKA (A126-B1 cells) permitted evaluation of the role(s) of ERK and PKA in the phosphorylation of the three phosphorylation sites and of the involvement of the three sites in depolarization-stimulated CA biosynthesis. Our results indicate that PKA is predominantly responsible for depolarization-dependent increases in Ser40 phosphorylation but that ERK1/ERK2 activation and Ser31 phosphorylation are responsible for the depolarization-dependent increases in CA biosynthesis.
Protein kinases and site-speci®c phosphorylation
Ser31
The MEK inhibitor PD98059 decreased basal Ser31 PS and completely prevented the elevated K 1 stimulation of Ser31 PS in both the PC12 and A126-B1 cells. Similarly, PD98059 pretreatment completely prevented the elevated K 1 stimulation of ERK1/ERK2 phosphorylation. Only slight effects of PD98059 on Ser19 PS were observed. PD98059 pretreatment increased basal Ser40 PS in PC12 cells but not in A126-B1 cells, suggesting that there is`cross-talk' between the ERK and PKA pathways in PC12 cells. Although these data do not distinguish between ERK1 and ERK2 (both of which selectively phosphorylate Ser31 in vitro; , they indicate that ERK1/ERK2 mediate the depolarization-dependent phosphorylation of Ser31, as previously suggested for PC12 cells Halloran and Vulliet 1994) and bovine chromaf®n cells (Thomas et al. 1997) .
Ser19
CAMKII has been the primary candidate for mediating depolarization-dependent Ser19 phosphorylation in situ because it phosphorylates Ser19 in vitro and its activation and Ser19 phosphorylation both exhibit similarly rapid increases in response to depolarization (Haycock 1993a; Tsutsui et al. 1994) . CAMKII (but not CAMKIV) was present in both the PC12 and A126-B1 cells and elevated K 1 produced substantial increases in Ser19 PS. However, we were unable to show conclusively that CAMKII phosphorylates Ser19 under these conditions. The CAMKII inhibitor KN-93 (as well as its`inactive' congener, proved to be non-speci®c, as depolarization-stimulated increases in TH PS at all three sites were inhibited by both compounds. In fact, these compounds also inhibited the depolarization-dependent increase in ERK phosphorylation (data not shown). That KN-93 did not affect the selective NGF-dependent increase in Ser31 PS or forskolin-dependent increase in Ser40 PS supports the conclusion of Maurer et al. (1996) these compounds probably inhibit Ca 21 entry into intact cells. Thus, the protein kinase responsible for depolarization-dependent increases in Ser19 PS remains to be identi®ed.
Ser40
After treatment with elevated K 1 , Ser40 PS increased to about 0.05 in PC12 cells compared with 0.01 in A126-B1 cells, in which forskolin failed to elicit an increase in Ser40 PS. This difference in Ser40 PS suggests that PKA is primarily responsible for the depolarization-dependent increase in Ser40 PS. Arguably, the difference in Ser40 PS between the cell lines could be due to differences in their relative abundance of CAMKII (which phosphorylates Ser40 in vitro). However, the relative abundance of CAMKII was comparable in both cell lines, strengthening the conclusion that PKA phosphorylates Ser40 under depolarizing conditions. We did detect a consistent and slight increase in Ser40 PS in A126-B1 cells. Although CAMKIV was not detected, perhaps a small amount of Ser40 PS may be mediated by another calcium-dependent protein kinase, such as CAMKII (cf. Thomas et al. 1997) .
Site-speci®c phosphorylation and CA biosynthesis
Ser31
Although not previously demonstrated directly, a role for Ser31 phosphorylation in depolarization-stimulated CA biosynthesis can be inferred from previous studies. In AtT-20 cells transfected with TH in which Leu was substituted for either Ser19 or Ser40 (Harada et al. 1996) , elevated K 1 -stimulated CA biosynthesis did not differ between cells transfected with TH mutants and wild-type TH. However, the status of Ser31 PS was not determined in these studies, nor were potential interactions between phosphorylation sites (e.g. Ser19 and Ser31 in the Ser40 mutant cells). Our results show that increases in Ser31 PS, and Ser31 alone, are critical to the depolarizationdependent stimulation of CA biosynthesis. Elevated K 1 treatment resulted in an increase in phosphorylated (hence, activated) ERK, which phosphorylated Ser31 and in turn increased CA biosynthesis. Moreover, all of these effects were blocked by PD90859. That Ser31 phosphorylation is necessary and suf®cient for the depolarization-dependent increases in CA biosynthesis is further supported by the observations that PD98059 blocked increases in both Ser31 PS and CA biosynthesis in PC12 and A126-B1 cells and that NGF treatment (under conditions which mimicked the effects of elevated K 1 on Ser31 PS) increased CA biosynthesis to the same extent as elevated K 1 (,50% increase) in both cell lines.
Ser19
A potential involvement of Ser19 phosphorylation in depolarization-stimulated CA biosynthesis in intact cells has been inferred from the observation that the CAMKII inhibitors KN-93 and KN-62 inhibit depolarizationstimulated CA biosynthesis (Sumi et al. 1991; Marley and Thomson 1996) . However, our data shows that KN-93 inhibited the depolarization-dependent increases in phosphorylation at each of the TH sites. Thus, the inhibition of depolarization-stimulated Ser31 phosphorylation by KN-93 pretreatment that we observed is probably the reason behind the previously reported inhibitory effects of KN-93 on depolarization-stimulated TH activity and CA biosynthesis. In agreement with Marley and Thomson (1996) , who reported that KN-92 (the inactive congener) inhibited depolarizationstimulated TH activity, we found that KN-92 inhibited depolarization-stimulated ERK and Ser31 phosphorylation to an extent similar to that produced by . Our data also show that even though PD90859 pretreatment blocked the depolarization-dependent increases in CA, Ser19 PS was still increased about three-fold in both cell lines. From these data, and as supported by previous studies using alternative approaches Lindgren et al. 2000) , we conclude that neither Ser19 phosphorylation nor CAMKII phosphorylation of TH is directly involved in depolarizationstimulated CA biosynthesis.
Ser40
The disparity in Ser40 PS but not in the regulation of depolarization-stimulated CA biosynthesis between PC12 and A126-B1 cells suggests that Ser40 phosphorylation plays little or no role in depolarization-dependent CA biosynthesis. Yet, PKA-mediated phosphorylation of Ser40 could play a role in regulating CA biosynthesis under other conditions. Several reports have shown a direct relationship of Ser40 phosphorylation with regulating TH activity or CA biosynthesis in situ and in vivo (Waymire et al. 1991; Lew et al. 1998; Lindgren et al. 2000 Lindgren et al. , 2001 . The apparent lack of relationship between Ser40 phosphorylation and CA biosynthesis under depolarizing conditions may be that an inadequate level of Ser40 PS is achieved under depolarizing conditions in PC12 cells. For example, whereas forskolin at a concentration that increased Ser40 PS to 0.05 (i.e. similar to that produced by elevated K 1 ) did not stimulate CA biosynthesis, a 10-fold higher forskolin concentration increased Ser40 PS to 0.09 and increased CA biosynthesis 1.7-fold. Therefore, a certain threshold of PS at Ser40 may have to be reached before an effect on CA biosynthesis occurs. Agents that affect PKA activity such as neuropeptides, NMDA agonists, or D2 autoreceptor ligands (Waymire et al. 1991; Lindgren et al. 2000 Lindgren et al. , 2001 , alone or in combination with depolarization, may increase Ser40 PS suf®ciently to increase CA biosynthesis.
Implications for CA biosynthesis in vivo
The present evidence that thresholds of PS must be exceeded in order to in¯uence CA biosynthesis may have implications for CA function in the CNS. Ser40 PS in the striatum, nucleus accumbens, substantia nigra, and ventral tegmental area (VTA) is ,0.03 (Salvatore et al. 2000) , similar to that in PC12 cells. Ser31 PS in the substantia nigra and ventral tegmental area (,0.10) and Ser19 PS in the striatum (,0.10) are also similar to those in PC12 cells. We reported the effects of haloperidol on TH PS in vivo in these dopaminergic brain regions and compared these results with previous work in which the effects of haloperidol on TH activity and CA biosynthesis had been reported. Haloperidol has been reported to have far less in¯uence on TH activity and CA biosynthesis in cell body regions than in terminal ®eld regions. After acute haloperidol, Ser40 PS was increased to a greater extent in the terminal ®eld than in the cell body regions whereas Ser31 PS was increased to the same extent in both regions. The conclusion from these observations was that Ser40 PS, and not Ser31 PS, was associated with the regional differences in the effects of haloperidol on CA biosynthesis. However, the actual difference in Ser31 PS between the terminal ®eld and cell body regions associated with acute haloperidol was about 0.40 (0.50±0.60 PS in the terminal ®eld regions versus 0.15±0.20 PS in the cell body regions). The ®ndings of the present PC12 study emphasize that it is the absolute level of PS, and not the percent of control increase in PS, that in¯uences CA biosynthesis. Thus the large difference in Ser31 PS between the terminal ®eld and cell body regions could be a major factor in the regional differences in CA biosynthesis observed after acute haloperidol.
Our present results indicate that ERK-mediated phosphorylation of Ser31, but not PKA-mediated phosphorylation of Ser40, is critical for replenishing CA not only secreted from PC12 cells under depolarizing conditions but, as supported in the preceding paragraph, lost during neuronal activity in dopaminergic brain regions. These ®ndings, coupled with previous biochemical investigations into the etiology of neurological diseases involving CA systems make it plausible that Ser31 phosphorylation of TH plays a role in these diseases. For example, chronic administration of morphine or cocaine increases phospho-ERK immunoreactivity in the VTA (Berhow et al. 1996) , suggesting that dopamine biosynthesis may be elevated in this region. In fact, amphetamine-sensitive rats have an increase in striatal NGF-related neurotrophin expression and TH activity (Solbrig et al. 2000) . In addition, agents that affect PKA activity can in¯uence cocaine self-administration (Self et al. 1998) , and elevated impulse activity in midbrain dopamine neurons is associated with increased vulnerability to cocaine self-administration (Marinelli and White 2000) . Thus, that both ERK and PKA are activated by depolarization underscores the importance of considering the regulation of both of Ser31 and Ser40 phosphorylation in such behavioral paradigms.
